Norway· NO-ID_137CE4E4-E238-45C8-A00E-A3B9DEEFCD28
Juluca
A dolutegravir and rilpivirine product containing rilpivirine + dolutegravir, registered in Norway by ViiV Healthcare BV (1). The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Dolutegravir and rilpivirine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR21 (dolutegravir and rilpivirine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Dolutegravir and rilpivirine · ATC J05AR21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Rilpivirine + Dolutegravir
- Manufacturer
- ViiV Healthcare BV (1)
- Country
- Norway (NO)
- ATC code
- J05AR21
- ATC class
- Dolutegravir and rilpivirine
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_137CE4E4-E238-45C8-A00E-A3B9DEEFCD28
- no_varenummer53494730NOK 11461.7
- gtin7046265349471
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dolutegravir and rilpivirine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandJulucaAbacus Medicine A/S
- CzechiaJULUCAViiV Healthcare BV, Amersfoort
- United StatesJulucaViiV Healthcare Company
- FranceJULUCA 50 mg/25 mg, comprimé pelliculéVIIV HEALTHCARE (PAYS-BAS)
- CanadaJULUCAVIIV HEALTHCARE ULC
- IcelandJulucaViiV Healthcare BV
- NetherlandsJuluca 50 mg/25 mg, filmomhulde tablettenViiV healthcare B.V.
- PolandJulucaViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Juluca
- Liechtenstein · Juluca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/53afc2a4-77b9-4f25-a90a-c9d57ecfa8e2 GET /v1/drugs/53afc2a4-77b9-4f25-a90a-c9d57ecfa8e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Dolutegravir og rilpivirin",
"merkevare_id": "ID_137CE4E4-E238-45C8-A00E-A3B9DEEFCD28",
"name_form_strength": "Juluca tab 50 mg/25 mg",
"prescription_group": "C"
}See everything about dolutegravir and rilpivirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.